-
The treatment of advanced non-small-cell lung cancer with anaplastic lymphoma kinase genetic alterations: reality and hopes
Assunta Sgambato, Francesca Casaluce, Antonio Rossi, Paolo Maione, Paola Claudia Sacco, Fortunato Ciardiello & Cesare Gridelli
Clinical Trail Outcomes: Clinical Investigation
-
The treatment of advanced non-small-cell lung cancer with anaplastic lymphoma kinase genetic alterations: reality and hopes
Assunta Sgambato, Francesca Casaluce, Antonio Rossi, Paolo Maione, Paola Claudia Sacco, Fortunato Ciardiello & Cesare Gridelli
Clinical Trail Outcomes: Clinical Investigation
-
The treatment of advanced non-small-cell lung cancer with anaplastic lymphoma kinase genetic alterations: reality and hopes
Assunta Sgambato, Francesca Casaluce, Antonio Rossi, Paolo Maione, Paola Claudia Sacco, Fortunato Ciardiello & Cesare Gridelli
Clinical Trail Outcomes: Clinical Investigation
-
The treatment of advanced non-small-cell lung cancer with anaplastic lymphoma kinase genetic alterations: reality and hopes
Assunta Sgambato, Francesca Casaluce, Antonio Rossi, Paolo Maione, Paola Claudia Sacco, Fortunato Ciardiello & Cesare Gridelli
Clinical Trail Outcomes: Clinical Investigation
-
The treatment of advanced non-small-cell lung cancer with anaplastic lymphoma kinase genetic alterations: reality and hopes
Assunta Sgambato, Francesca Casaluce, Antonio Rossi, Paolo Maione, Paola Claudia Sacco, Fortunato Ciardiello & Cesare Gridelli
Clinical Trail Outcomes: Clinical Investigation
-
The treatment of advanced non-small-cell lung cancer with anaplastic lymphoma kinase genetic alterations: reality and hopes
Assunta Sgambato, Francesca Casaluce, Antonio Rossi, Paolo Maione, Paola Claudia Sacco, Fortunato Ciardiello & Cesare Gridelli
Clinical Trail Outcomes: Clinical Investigation
-
The treatment of advanced non-small-cell lung cancer with anaplastic lymphoma kinase genetic alterations: reality and hopes
Assunta Sgambato, Francesca Casaluce, Antonio Rossi, Paolo Maione, Paola Claudia Sacco, Fortunato Ciardiello & Cesare Gridelli
Clinical Trail Outcomes: Clinical Investigation
-
The treatment of advanced non-small-cell lung cancer with anaplastic lymphoma kinase genetic alterations: reality and hopes
Assunta Sgambato, Francesca Casaluce, Antonio Rossi, Paolo Maione, Paola Claudia Sacco, Fortunato Ciardiello & Cesare Gridelli
Clinical Trail Outcomes: Clinical Investigation
-
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer
Kouji Izumi, Lei Li & Chawnshang Chang
Clinical Trail Outcomes: Clinical Investigation
-
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer
Kouji Izumi, Lei Li & Chawnshang Chang
Clinical Trail Outcomes: Clinical Investigation
-
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer
Kouji Izumi, Lei Li & Chawnshang Chang
Clinical Trail Outcomes: Clinical Investigation
-
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer
Kouji Izumi, Lei Li & Chawnshang Chang
Clinical Trail Outcomes: Clinical Investigation
-
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer
Kouji Izumi, Lei Li & Chawnshang Chang
Clinical Trail Outcomes: Clinical Investigation
-
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer
Kouji Izumi, Lei Li & Chawnshang Chang
Clinical Trail Outcomes: Clinical Investigation
-
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer
Kouji Izumi, Lei Li & Chawnshang Chang
Clinical Trail Outcomes: Clinical Investigation
-
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer
Kouji Izumi, Lei Li & Chawnshang Chang
Clinical Trail Outcomes: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 9
Acknowledgements: Clinical Investigation
-
Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis
Michael W Konstan, Drucy Borowitz, Nicole Mayer-Hamblett, Carlos Milla, Leslie Hendeles, Susan Murray, Richard A Kronmal, Susan Casey, Lynn M Rose, Wayne J Morgan,Bonnie W Ramsey
Clinical Trail Prospective: Clinical Investigation
-
Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis
Michael W Konstan, Drucy Borowitz, Nicole Mayer-Hamblett, Carlos Milla, Leslie Hendeles, Susan Murray, Richard A Kronmal, Susan Casey, Lynn M Rose, Wayne J Morgan,Bonnie W Ramsey
Clinical Trail Prospective: Clinical Investigation
-
Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis
Michael W Konstan, Drucy Borowitz, Nicole Mayer-Hamblett, Carlos Milla, Leslie Hendeles, Susan Murray, Richard A Kronmal, Susan Casey, Lynn M Rose, Wayne J Morgan,Bonnie W Ramsey
Clinical Trail Prospective: Clinical Investigation
-
Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis
Michael W Konstan, Drucy Borowitz, Nicole Mayer-Hamblett, Carlos Milla, Leslie Hendeles, Susan Murray, Richard A Kronmal, Susan Casey, Lynn M Rose, Wayne J Morgan,Bonnie W Ramsey
Clinical Trail Prospective: Clinical Investigation
-
Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis
Michael W Konstan, Drucy Borowitz, Nicole Mayer-Hamblett, Carlos Milla, Leslie Hendeles, Susan Murray, Richard A Kronmal, Susan Casey, Lynn M Rose, Wayne J Morgan,Bonnie W Ramsey
Clinical Trail Prospective: Clinical Investigation
-
Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis
Michael W Konstan, Drucy Borowitz, Nicole Mayer-Hamblett, Carlos Milla, Leslie Hendeles, Susan Murray, Richard A Kronmal, Susan Casey, Lynn M Rose, Wayne J Morgan,Bonnie W Ramsey
Clinical Trail Prospective: Clinical Investigation
-
Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis
Michael W Konstan, Drucy Borowitz, Nicole Mayer-Hamblett, Carlos Milla, Leslie Hendeles, Susan Murray, Richard A Kronmal, Susan Casey, Lynn M Rose, Wayne J Morgan,Bonnie W Ramsey
Clinical Trail Prospective: Clinical Investigation
-
Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis
Michael W Konstan, Drucy Borowitz, Nicole Mayer-Hamblett, Carlos Milla, Leslie Hendeles, Susan Murray, Richard A Kronmal, Susan Casey, Lynn M Rose, Wayne J Morgan,Bonnie W Ramsey
Clinical Trail Prospective: Clinical Investigation
-
Telavancin in the treatment of nosocomial pneumonia: review of the clinical evidence
Antoni Torres
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telavancin in the treatment of nosocomial pneumonia: review of the clinical evidence
Antoni Torres
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telavancin in the treatment of nosocomial pneumonia: review of the clinical evidence
Antoni Torres
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telavancin in the treatment of nosocomial pneumonia: review of the clinical evidence
Antoni Torres
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telavancin in the treatment of nosocomial pneumonia: review of the clinical evidence
Antoni Torres
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telavancin in the treatment of nosocomial pneumonia: review of the clinical evidence
Antoni Torres
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telavancin in the treatment of nosocomial pneumonia: review of the clinical evidence
Antoni Torres
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telavancin in the treatment of nosocomial pneumonia: review of the clinical evidence
Antoni Torres
Review: Clinical Trail Outcomes: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Joseph Kuti
Joseph Kuti
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Joseph Kuti
Joseph Kuti
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Joseph Kuti
Joseph Kuti
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Joseph Kuti
Joseph Kuti
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Joseph Kuti
Joseph Kuti
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Joseph Kuti
Joseph Kuti
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Joseph Kuti
Joseph Kuti
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Joseph Kuti
Joseph Kuti
Interview: Clinical Investigation